Jason A Keyes's Net Worth
$44.9 Thousand
Who is Jason A Keyes?
Jason A Keyes does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Orexigen Therapeutics, Inc., Sesen Bio, Inc., Equillium, Inc., and ACTUATE THERAPEUTICS, INC..
SEC CIK
Jason A Keyes's CIK is 0001678152
Past Insider Trading and Trends
2020 was Jason A Keyes's most active year for acquiring shares with 6 total transactions. Jason A Keyes's most active month to acquire stocks was the month of May. 2020 was Jason A Keyes's most active year for disposing of shares, totalling 2 transactions. Jason A Keyes's most active month to dispose stocks was the month of March. 2021 saw Jason A Keyes paying a total of $26,132.00 for 203,620 shares, this is the most they've acquired in one year. In 2020 Jason A Keyes cashed out on 160,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Orexigen Therapeutics, Inc. No price found
EVP, Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
| +22.51% | 557 |
$1.55 | $863.35 | 3.03K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| +13.33% | 291 |
$1.67 | $485.97 | 2.47K |
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sesen Bio, Inc. (CARM) Snapshot price: $0.9803
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 40K |
—
|
—
| 40K |
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Equillium, Inc. (EQ) Snapshot price: $1
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.87% | -10.00K |
$0.87 | -$8,700.00 | 67.72K |
Scheduled
|
Jul 16
| ||
Form 4
| +67.81% | 23.8K |
$0.57 | $13,506.90 | 58.91K |
Jun 9 - Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
| +14.49% | 4.44K |
$1.19 | $5,288.36 | 35.11K |
Dec 9 - Jan 3
| |||
Form 4
| -8.26% | -7.00K |
$2.83 | -$19,810.00 | 77.72K |
Scheduled
|
Aug 29
| ||
Form 4
| -5.57% | -5.00K |
$2.52 | -$12,600.00 | 84.72K |
Scheduled
|
Jun 6
| ||
Form 4
| -8.19% | -8.00K |
$3.18 | -$25,440.00 | 89.72K |
Scheduled
|
Apr 4
| ||
Form 4
| +31.53% | 5.58K |
$2.35 | $13,124.75 | 23.3K |
Dec 10
| |||
Form 4
| -4.87% | -5.00K |
$5.08 | -$25,401.50 | 97.72K |
Scheduled
|
Dec 1
| ||
Form 4
| -7.23% | -8.00K |
$6.74 | -$53,924.00 | 102.72K |
Scheduled
|
Sep 27
| ||
Form 4
| -4.32% | -5.00K |
$5.72 | -$28,585.00 | 110.72K |
Scheduled
|
Jul 27
| ||
Form 4
| +45.46% | 5.54K |
$2.35 | $13,007.25 | 17.71K |
Jun 10
| |||
Form 4/A
| -4.14% | -5.00K |
$6.50 | -$32,483.50 | 115.72K |
Scheduled
|
May 26
| ||
Form 4
| -4.14% | -5.00K |
$6.50 | -$32,483.50 | 115.72K |
Scheduled
|
May 26
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| -6.22% | -8.00K |
$4.74 | -$37,913.60 | 120.72K |
Scheduled
|
Dec 23
| ||
Form 4
| +78.69% | 5.36K |
$2.35 | $12,600.70 | 12.18K |
Dec 10
| |||
Form 4
| +278.56% | 5.01K |
$2.41 | $12,083.74 | 6.81K |
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 4
| -3.69% | -5.00K |
$5.03 | -$25,137.50 | 130.52K |
Scheduled
|
Feb 18
| ||
Form 4
| -3.56% | -5.00K |
$4.41 | -$22,043.00 | 135.52K |
Scheduled
|
Jan 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
| -3.48% | -5.00K |
$3.60 | -$17,980.50 | 138.72K |
Scheduled
|
Sep 3
| ||
Form 4
| -3.36% | -5.00K |
$3.99 | -$19,941.00 | 143.72K |
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACTUATE THERAPEUTICS, INC. (ACTU) Snapshot price: $8.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||